Preclinical Evidence for the Interplay between Oxidative Stress and RIP1-Dependent Cell Death in Neurodegeneration: State of the Art and Possible Therapeutic Implications

Neurodegenerative diseases are the most frequent chronic, age-associated neurological pathologies having a major impact on the patient’s quality of life. Despite a heavy medical, social and economic burden they pose, no causative treatment is available for these diseases. Among the important pathoge...

Full description

Bibliographic Details
Main Authors: Danuta Jantas, Władysław Lasoń
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/10/10/1518
_version_ 1797515506963447808
author Danuta Jantas
Władysław Lasoń
author_facet Danuta Jantas
Władysław Lasoń
author_sort Danuta Jantas
collection DOAJ
description Neurodegenerative diseases are the most frequent chronic, age-associated neurological pathologies having a major impact on the patient’s quality of life. Despite a heavy medical, social and economic burden they pose, no causative treatment is available for these diseases. Among the important pathogenic factors contributing to neuronal loss during neurodegeneration is elevated oxidative stress resulting from a disturbed balance between endogenous prooxidant and antioxidant systems. For many years, it was thought that increased oxidative stress was a cause of neuronal cell death executed via an apoptotic mechanism. However, in recent years it has been postulated that rather programmed necrosis (necroptosis) is the key form of neuronal death in the course of neurodegenerative diseases. Such assumption was supported by biochemical and morphological features of the dying cells as well as by the fact that various necroptosis inhibitors were neuroprotective in cellular and animal models of neurodegenerative diseases. In this review, we discuss the relationship between oxidative stress and RIP1-dependent necroptosis and apoptosis in the context of the pathomechanism of neurodegenerative disorders. Based on the published data mainly from cellular models of neurodegeneration linking oxidative stress and necroptosis, we postulate that administration of multipotential neuroprotectants with antioxidant and antinecroptotic properties may constitute an efficient pharmacotherapeutic strategy for the treatment of neurodegenerative diseases.
first_indexed 2024-03-10T06:46:23Z
format Article
id doaj.art-84b17eb5aba240cfb2e4f03ad7ece2f1
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-10T06:46:23Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-84b17eb5aba240cfb2e4f03ad7ece2f12023-11-22T17:15:09ZengMDPI AGAntioxidants2076-39212021-09-011010151810.3390/antiox10101518Preclinical Evidence for the Interplay between Oxidative Stress and RIP1-Dependent Cell Death in Neurodegeneration: State of the Art and Possible Therapeutic ImplicationsDanuta Jantas0Władysław Lasoń1Maj Institute of Pharmacology Polish Academy of Sciences, Department of Experimental Neuroendocrinology, Smetna Street 12, PL 31-343 Krakow, PolandMaj Institute of Pharmacology Polish Academy of Sciences, Department of Experimental Neuroendocrinology, Smetna Street 12, PL 31-343 Krakow, PolandNeurodegenerative diseases are the most frequent chronic, age-associated neurological pathologies having a major impact on the patient’s quality of life. Despite a heavy medical, social and economic burden they pose, no causative treatment is available for these diseases. Among the important pathogenic factors contributing to neuronal loss during neurodegeneration is elevated oxidative stress resulting from a disturbed balance between endogenous prooxidant and antioxidant systems. For many years, it was thought that increased oxidative stress was a cause of neuronal cell death executed via an apoptotic mechanism. However, in recent years it has been postulated that rather programmed necrosis (necroptosis) is the key form of neuronal death in the course of neurodegenerative diseases. Such assumption was supported by biochemical and morphological features of the dying cells as well as by the fact that various necroptosis inhibitors were neuroprotective in cellular and animal models of neurodegenerative diseases. In this review, we discuss the relationship between oxidative stress and RIP1-dependent necroptosis and apoptosis in the context of the pathomechanism of neurodegenerative disorders. Based on the published data mainly from cellular models of neurodegeneration linking oxidative stress and necroptosis, we postulate that administration of multipotential neuroprotectants with antioxidant and antinecroptotic properties may constitute an efficient pharmacotherapeutic strategy for the treatment of neurodegenerative diseases.https://www.mdpi.com/2076-3921/10/10/1518neurodegenerative diseasesneuroprotectionnecrostatin-1necroptosis inhibitorsoxytosisbrain ischemia
spellingShingle Danuta Jantas
Władysław Lasoń
Preclinical Evidence for the Interplay between Oxidative Stress and RIP1-Dependent Cell Death in Neurodegeneration: State of the Art and Possible Therapeutic Implications
Antioxidants
neurodegenerative diseases
neuroprotection
necrostatin-1
necroptosis inhibitors
oxytosis
brain ischemia
title Preclinical Evidence for the Interplay between Oxidative Stress and RIP1-Dependent Cell Death in Neurodegeneration: State of the Art and Possible Therapeutic Implications
title_full Preclinical Evidence for the Interplay between Oxidative Stress and RIP1-Dependent Cell Death in Neurodegeneration: State of the Art and Possible Therapeutic Implications
title_fullStr Preclinical Evidence for the Interplay between Oxidative Stress and RIP1-Dependent Cell Death in Neurodegeneration: State of the Art and Possible Therapeutic Implications
title_full_unstemmed Preclinical Evidence for the Interplay between Oxidative Stress and RIP1-Dependent Cell Death in Neurodegeneration: State of the Art and Possible Therapeutic Implications
title_short Preclinical Evidence for the Interplay between Oxidative Stress and RIP1-Dependent Cell Death in Neurodegeneration: State of the Art and Possible Therapeutic Implications
title_sort preclinical evidence for the interplay between oxidative stress and rip1 dependent cell death in neurodegeneration state of the art and possible therapeutic implications
topic neurodegenerative diseases
neuroprotection
necrostatin-1
necroptosis inhibitors
oxytosis
brain ischemia
url https://www.mdpi.com/2076-3921/10/10/1518
work_keys_str_mv AT danutajantas preclinicalevidencefortheinterplaybetweenoxidativestressandrip1dependentcelldeathinneurodegenerationstateoftheartandpossibletherapeuticimplications
AT władysławlason preclinicalevidencefortheinterplaybetweenoxidativestressandrip1dependentcelldeathinneurodegenerationstateoftheartandpossibletherapeuticimplications